טוען...
Bevacizumab maintenance in metastatic colorectal cancer: How long?
The management of patients with non-progressive metastatic colorectal cancer after six months of treatment has not yet been codified. The most relevant concerns are the effectiveness of maintenance vs discontinuation, and the tolerability of prolonged treatment. Here we report the case of a 72-year-...
שמור ב:
| הוצא לאור ב: | World J Clin Cases |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4233413/ https://ncbi.nlm.nih.gov/pubmed/25405197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v2.i11.717 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|